134 related articles for article (PubMed ID: 35116880)
1. Alpha-actinin 4 and tumorigenesis of hepatocellular carcinoma.
Wang G; Li Y; Tang B; Yu Q
Transl Cancer Res; 2019 Aug; 8(4):1374-1380. PubMed ID: 35116880
[TBL] [Abstract][Full Text] [Related]
2. Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.
Zhu MX; Wei CY; Zhang PF; Gao DM; Chen J; Zhao Y; Dong SS; Liu BB
J Exp Clin Cancer Res; 2019 Sep; 38(1):409. PubMed ID: 31533816
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma.
Xie P; Chen Y; Zhang H; Zhou G; Chao Q; Wang J; Liu Y; Fang J; Xie J; Zhen J; Wang Z; Hao L; Huang D
Aging (Albany NY); 2021 Aug; 13(15):19317-19338. PubMed ID: 34380780
[TBL] [Abstract][Full Text] [Related]
4. Actinin-4 as a Diagnostic Biomarker in Serum of Breast Cancer Patients.
Fang C; Li JJ; Deng T; Li BH; Geng PL; Zeng XT
Med Sci Monit; 2019 May; 25():3298-3302. PubMed ID: 31054253
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
6. MTBP inhibits migration and metastasis of hepatocellular carcinoma.
Bi Q; Ranjan A; Fan R; Agarwal N; Welch DR; Weinman SA; Ding J; Iwakuma T
Clin Exp Metastasis; 2015 Apr; 32(4):301-11. PubMed ID: 25759210
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma.
Li YC; Wang D; Zhu GY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4855-4860. PubMed ID: 30070318
[TBL] [Abstract][Full Text] [Related]
8. Alpha-actinin 4 is associated with cancer cell motility and is a potential biomarker in non-small cell lung cancer.
Wang MC; Chang YH; Wu CC; Tyan YC; Chang HC; Goan YG; Lai WW; Cheng PN; Liao PC
J Thorac Oncol; 2015 Feb; 10(2):286-301. PubMed ID: 25299231
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
Chen XQ; He JR; Wang HY
Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
[TBL] [Abstract][Full Text] [Related]
12. Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma.
Sheng XR; Xing SG; Wang RD; Chen K; Jia WD
Onco Targets Ther; 2018; 11():909-917. PubMed ID: 29503566
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma.
Wang YB; Zhou BX; Ling YB; Xiong ZY; Li RX; Zhong YS; Xu MX; Lu Y; Liang H; Chen GH; Yao ZC; Deng MH
Gastroenterol Rep (Oxf); 2019 Oct; 7(5):354-360. PubMed ID: 31687155
[TBL] [Abstract][Full Text] [Related]
14. NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma.
Jing JS; Li H; Wang SC; Ma JM; Yu LQ; Zhou H
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413609
[TBL] [Abstract][Full Text] [Related]
15. ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas.
Yamamoto S; Tsuda H; Honda K; Takano M; Tamai S; Imoto I; Inazawa J; Yamada T; Matsubara O
Histopathology; 2012 Jun; 60(7):1073-83. PubMed ID: 22348389
[TBL] [Abstract][Full Text] [Related]
16. Association between the expression of carbonic anhydrase II and clinicopathological features of hepatocellular carcinoma.
Zhang H; Zhuo C; Zhou D; Zhang F; Chen M; Xu S; Chen Z
Oncol Lett; 2019 Jun; 17(6):5721-5728. PubMed ID: 31186798
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma.
Zhang K; Jiang L; He R; Li BL; Jia Z; Huang RH; Mu Y
Tumour Biol; 2014 Aug; 35(8):7669-73. PubMed ID: 24801906
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid receptor-related receptor alpha (RORalpha) is a prognostic marker for hepatocellular carcinoma.
Fu RD; Qiu CH; Chen HA; Zhang ZG; Lu MQ
Tumour Biol; 2014 Aug; 35(8):7603-10. PubMed ID: 24798975
[TBL] [Abstract][Full Text] [Related]
19. α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer.
An HT; Yoo S; Ko J
Oncogene; 2016 Nov; 35(45):5893-5904. PubMed ID: 27065319
[TBL] [Abstract][Full Text] [Related]
20. C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence.
Chen J; Chen J; Gong Y; Zou B; Liu X; Ding L; Huang J; Zhang B; Li J
J Invest Surg; 2020 Dec; 33(10):914-923. PubMed ID: 30907217
[No Abstract] [Full Text] [Related]
[Next] [New Search]